Insider · CIK 0001673401
Joaquin Duato
Files at JNJ (JOHNSON & JOHNSON). First filing Aug 25, 2025, latest Aug 14, 2026.
In brief
Joaquin Duato files SEC Form 4 as CEO, chair and director at JNJ (JOHNSON & JOHNSON). Since Aug 25, 2025, Joaquin Duato has reported 0 open-market buys worth $0 and 4 open-market sells worth $89M, the latest filed on Aug 14, 2026.
A track record needs three past buys with six months of prices behind them; Joaquin Duato has 0, so none is measured yet.
The newest scored trade: sold $32M of JNJ on Aug 13, 2026, filed Aug 14, 2026, scored 60 (notable). In the last 12 months: 0 buys worth $0 and 3 sells worth $67M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JNJ: JOHNSON & JOHNSON
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | JOHNSON & JOHNSON | $32M 123,291 shares | -31% | +54% from low-2% from high | |
| 70Notable | JOHNSON & JOHNSON | $13M 48,480 shares | -15% | +55% from low-4% from high | |
| 70Notable | JNJsell JOHNSON & JOHNSON | $22M 100,000 shares | -76% | +55% from low0% from high | |
| 60Notable | JOHNSON & JOHNSON | $23M 125,824 shares | -31% | +28% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 13, 2026 | JNJ JOHNSON & JOHNSON | 123,291 0.01% of outstanding | $32M | Aug 13, 2026 | $13M |
| Aug 5, 2026 | JNJ Johnson & Johnson | 48,480 0.00% of outstanding | $12M | Aug 5, 2026 | none |
| Jan 26, 2026 | JNJ Johnson & Johnson | 100,000 0.00% of outstanding | $22M | Jan 26, 2026 | none |
| Aug 22, 2025 | JNJ JOHNSON & JOHNSON | 125,824 0.01% of outstanding | $23M | Aug 22, 2025 | none |
Transactions
The newest 50 of 61 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +123,291 | $115.67 | $14M | 399,258 | Aug 14, 2026 |
| Aug 13, 2026 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stock | -20,976 | $262.00 | $5.5M | 378,282 | Aug 14, 2026 |
| Aug 13, 2026 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stock | -102,315 | $261.00 | $27M | 275,967 | Aug 14, 2026 |
| Aug 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -123,291 | $0.00 | $0 | 0 | Aug 14, 2026 |
| Aug 5, 2026 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stock | -41,957 | $258.06 | $11M | 282,490 | Aug 7, 2026 |
| Aug 5, 2026 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stock | -6,523 | $258.74 | $1.7M | 275,967 | Aug 7, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +3,469 | $0.00 | $0 | 279,436 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -989 | $244.55 | $242k | 278,447 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +73,054 | $0.00 | $0 | 351,501 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -31,679 | $244.55 | $7.7M | 319,822 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +3,682 | $0.00 | $0 | 323,504 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -1,602 | $243.45 | $390k | 321,902 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +4,505 | $0.00 | $0 | 326,407 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -1,960 | $243.45 | $477k | 324,447 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -3,469 | $0.00 | $0 | 0 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Performance Share Unitsderivative | -73,054 | $0.00 | $0 | 0 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -3,682 | $0.00 | $0 | 3,682 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -4,505 | $0.00 | $0 | 9,008 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Employee Stock Options (Right to Buy)derivative | +131,734 | $0.00 | $0 | 131,734 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Restricted Share Unitsderivative | +9,459 | $0.00 | $0 | 9,459 | Feb 18, 2026 |
| Feb 9, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Performance Share Unitsderivative | +73,054 | $0.00 | $0 | 73,054 | Feb 11, 2026 |
| Jan 26, 2026 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stockindirect: By spouse | -51,218 | $220.99 | $11M | 79,634 | Jan 28, 2026 |
| Jan 26, 2026 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stockindirect: By spouse | -48,782 | $221.48 | $11M | 30,852 | Jan 28, 2026 |
| Aug 22, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +125,824 | $101.87 | $13M | 401,791 | Aug 25, 2025 |
| Aug 22, 2025 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stock | -125,824 | $179.21 | $23M | 275,967 | Aug 25, 2025 |
| Aug 22, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -125,824 | $101.87 | $13M | 0 | Aug 25, 2025 |
| Mar 18, 2025 | JNJ JOHNSON & JOHNSON | GGift Common Stock | -130,852 | $0.00 | $0 | 275,967 | Mar 19, 2025 |
| Mar 18, 2025 | JNJ JOHNSON & JOHNSON | GGift Common Stockindirect: By spouse | +130,852 | $0.00 | $0 | 130,852 | Mar 19, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Employee Stock Options (Right to Buy)derivative | +219,020 | $0.00 | $0 | 219,020 | Feb 19, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Restricted Share Unitsderivative | +13,513 | $0.00 | $0 | 13,513 | Feb 19, 2025 |
| Feb 13, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +3,470 | $0.00 | $0 | 392,498 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -1,510 | $155.26 | $234k | 390,988 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +5,053 | $0.00 | $0 | 396,041 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -2,198 | $156.71 | $344k | 393,843 | Feb 18, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +3,682 | $0.00 | $0 | 397,525 | Feb 18, 2025 |
| Feb 18, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -1,602 | $156.15 | $250k | 395,923 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +19,282 | $0.00 | $0 | 415,205 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -8,386 | $156.71 | $1.3M | 406,819 | Feb 18, 2025 |
| Feb 13, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -3,470 | $0.00 | $0 | 3,469 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -5,053 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -3,682 | $0.00 | $0 | 7,364 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Performance Share Unitsderivative | -19,282 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 10, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Performance Share Unitsderivative | +19,282 | $0.00 | $0 | 19,282 | Feb 12, 2025 |
| Feb 7, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +126,369 | $100.06 | $13M | 489,671 | Feb 11, 2025 |
| Feb 7, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -100,643 | $153.12 | $15M | 389,028 | Feb 11, 2025 |
| Feb 7, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -126,369 | $100.06 | $13M | 0 | Feb 11, 2025 |
| Feb 15, 2024 | JNJ JOHNSON & JOHNSON | AGrant or award Employee Stock Options (Right to Buy)derivative | +177,816 | $0.00 | $0 | 177,816 | Feb 20, 2024 |
| Feb 15, 2024 | JNJ JOHNSON & JOHNSON | AGrant or award Restricted Share Unitsderivative | +11,046 | $0.00 | $0 | 11,046 | Feb 20, 2024 |
| Feb 13, 2024 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +3,470 | $0.00 | $0 | 364,809 | Feb 15, 2024 |
| Feb 13, 2024 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -1,507 | $157.85 | $238k | 363,302 | Feb 15, 2024 |
Questions about Joaquin Duato
Answered from the filings on this page, as of the latest one.
Is Joaquin Duato buying or selling?
In the last 12 months Joaquin Duato reported 0 open-market buys worth $0 and 3 open-market sells worth $67M on SEC Form 4; the latest was sold $32M of JNJ on Aug 13, 2026. Grants, option exercises and tax withholding are not counted.
How did Joaquin Duato's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joaquin Duato has 0.
Where does Joaquin Duato file Form 4?
Joaquin Duato has filed Form 4 at JNJ (JOHNSON & JOHNSON) as CEO and Chairman of the Board. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.